inositol and imatinib mesylate

inositol has been researched along with imatinib mesylate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Fioretos, T; Gullberg, U; Lassen, C; Olofsson, T; Richter, J; Svensson, E; Vidovic, K	1

Other Studies

2 other study(ies) available for inositol and imatinib mesylate

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Deregulation of the Wilms' tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells. Leukemia, 2007, Volume: 21, Issue:12 Topics: Apoptosis; Benzamides; Cell Line, Tumor; Cells, Cultured; Chromones; Drug Resistance, Neoplasm; Etoposide; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Genes, Wilms Tumor; Hematopoietic Stem Cells; Humans; Imatinib Mesylate; Inositol; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Morpholines; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Recombinant Fusion Proteins; RNA, Neoplasm; Signal Transduction; Transduction, Genetic; WT1 Proteins	2007

Article

Year

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

Chemical research in toxicology, 2010, Volume: 23, Issue:1

Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010

Deregulation of the Wilms' tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells.

Leukemia, 2007, Volume: 21, Issue:12

Topics: Apoptosis; Benzamides; Cell Line, Tumor; Cells, Cultured; Chromones; Drug Resistance, Neoplasm; Etoposide; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Genes, Wilms Tumor; Hematopoietic Stem Cells; Humans; Imatinib Mesylate; Inositol; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Morpholines; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Recombinant Fusion Proteins; RNA, Neoplasm; Signal Transduction; Transduction, Genetic; WT1 Proteins

2007